
Sign up to save your podcasts
Or


Based on Podcast App listening data
The Covid public health emergency, which looks likely to end as soon as April, could curtail access to drugs used to treat substance use disorders and mental illnesses. Ben Leonard talks with Ruth Reader about what's holding the DEA back from setting up a special registration process.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Federal officials are paying attention to promising programs emerging on the frontlines of the opioid epidemic — in prisons and jails. Krista Mahr talks with Ben Leonard about her report out of the Maine State Prison.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Alice Miranda Ollstein talks with Adam Cancryn about his report that senior Biden officials are targeting an end to the Covid-19 emergency designation, which would trigger a complex restructuring of major elements of the federal response.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Ben Leonard talks with Lauren Gardner about the debate over HHS's directive requiring doctors to send patients test results before they have a chance to explain them.
Learn more about your ad choices. Visit megaphone.fm/adchoices
On Friday, the FDA granted accelerated approval to Leqembi, previously known as lecanemab, made by Eisai and Biogen. The drug is the second that targets amyloid proteins in the brain, which are thought to cause progressive dementia. Katherine Ellen Foley talks with Megan Messerly about the future of the drug.
Learn more about your ad choices. Visit megaphone.fm/adchoices
According to the latest data from the HHS’ Substance Abuse and Mental Health Services Administration annual survey, one in three Americans had a substance abuse disorder or mental illness in 2021. Lauren Gardner talks with Daniel Payne. Plus, Ben Leonard talks with Amy Abernethy, the former No. 2 at the Food and Drug Administration and now president of Verily’s clinical research business, about barriers to improving trials, the new Advanced Research Projects Agency for Health and more.
Learn more about your ad choices. Visit megaphone.fm/adchoices
The coronavirus Omicron strain XBB.1.5, which has become the dominant strain in the U.S. in just a matter of weeks, could drive a new wave of cases, a World Health Organization official told reporters Wednesday. Lauren Gardner talks with Carmen Paun about what the WHO knows and what it doesn't — yet.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Katherine Ellen Foley talks with Alice Miranda Ollstein about the influx of new demands that anti-abortion groups have presented to the 118th Congress.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Katherine Ellen Foley talks with Ruth Reader about the state of artificial intelligence in health care and why it hasn’t reached its promise yet.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Carmen Paun talks with Daniel Payne about the trajectory of the mpox outbreak in 2022 and what lessons we can learn from it.
Learn more about your ad choices. Visit megaphone.fm/adchoices
From the publisher's feed

609 Listeners

1,520 Listeners

705 Listeners

111,800 Listeners

962 Listeners

307 Listeners

56,388 Listeners

102 Listeners

491 Listeners

206 Listeners

641 Listeners

6,444 Listeners

140 Listeners

390 Listeners

34 Listeners

16 Listeners

740 Listeners